02367 GIANT BIOGENE
- 51.350
- -0.400-0.77%
GIANT BIOGENE News
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2024
GIANT BIOGENE: INTERIM REPORT 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
GIANT BIOGENE: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
GIANT BIOGENE: DATE OF BOARD MEETING
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024
GIANT BIOGENE: New Arrangements on Dissemination of Corporate Communications to Non-Registered Shareholders
GIANT BIOGENE: New Arrangements on Dissemination of Corporate Communications to Registered Shareholders
GIANT BIOGENE: Fourth Amended And Restated Memorandum And Articles of Association
GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023 (Updated)
GIANT BIOGENE: Final Dividend for the Year Ended 31 December 2023 (Updated)
GIANT BIOGENE: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 13, 2024 AND PAYMENT OF FINAL DIVIDEND AND SPECIAL DIVIDEND
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024
GIANT BIOGENE: Next Day Disclosure Return
GIANT BIOGENE: COMPLETION OFPLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OFNEW SHARES UNDER THE GENERAL MANDATE
GIANT BIOGENE: PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OFNEW SHARES UNDER THE GENERAL MANDATE
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024
No Data
